|
Antiphospholipid Syndrome Collaborative Registry (APSCORE) Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Antiphospholipid Syndrome Collaborative Registry (APSCORE) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Antiphospholipid Syndrome Collaborative Registry (APSCORE) Clinical research trials and Antiphospholipid Syndrome Collaborative Registry (APSCORE) healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Antiphospholipid Syndrome Collaborative Registry (APSCORE). Antiphospholipid Syndrome Collaborative Registry (APSCORE) Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Antiphospholipid Syndrome Collaborative Registry (APSCORE) clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Antiphospholipid Syndrome Collaborative Registry (APSCORE) condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Antiphospholipid Syndrome Collaborative Registry (APSCORE)  Antiphospholipid Syndrome Collaborative Registry (APSCORE)
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
For Condition: Antiphospholipid Syndrome
Status: Recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) , National Center on Minority Health and Health Disparities (NCMHD)
Synopsis: Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, including heart attacks and strokes. APS may occur in people with systemic lupus erythematosus and other autoimmune diseases, or in otherwise healthy individuals. The Antiphospholipid Syndrome Collaborative Registry (APSCORE) is a national registry and tissue repository for patients with APS. This registry will collect clinical information and blood samples from people with APS.
Details: Registry participants will have a blood sample drawn and will be interviewed about their medical histories. Participants will be asked to return for a follow-up visit after two years. Clinical, demographic, and laboratory data will be collected. Registry resources will be made available to researchers and medical practitioners to support a broad range of research on the causes, diagnosis, mechanisms, and treatment of APS. The University of North Carolina at Chapel Hill is the coordinating center and an enrollment site for the registry. There are seven other enrollment sites: Ball Memorial Hospital, Muncie, IN; Duke University, Durham, NC; Hospital for Special Surgery, New York, NY; Johns Hopkins University, Baltimore, MD; Morehouse School of Medicine, Atlanta, GA; University of Texas Health Science Center, San Antonio, TX; and University of Utah Health Science Center, Salt Lake City, UT.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Antiphospholipid antibodies with or without associated clinical manifestations
Total Enrollment: 2000
Location and Contact Information:
University of Texas Health Science Center *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Amy Saklad 210-567-1437
Ball Memorial Hospital *Recruiting*
Muncie, Indiana, 47303
United States
Recruiting Sherry Simmonds 765-747-8458
Morehouse School of Medicine *Recruiting*
Atlanta, Georgia, 30310
United States
Recruiting Casmir Nwigwe 404-756-5215
Hospital for Special Surgery, Weill-Cornell University Medical Center *Recruiting*
New York City, New York, 10021
United States
Recruiting Victoria Kaplan 212-774-2808
Johns Hopkins University *Recruiting*
Baltimore, Maryland, 21205
United States
Recruiting Janice Lin 410-614-1574
University of Utah Health Science Center *Recruiting*
Salt Lake City, Utah, 84132
United States
Recruiting Jurhee Rice 801-581-6196
Duke University Medical Center *Recruiting*
Durham, North Carolina, 27710
United States
Recruiting Melissa Britt 919-684-5350
University of North Carolina at Chapel Hill *Recruiting*
Chapel Hill, North Carolina, 27599
United States
Recruiting Gail Buxton 919-966-0572
Additional Information:
Study ID Numbers: NIAMS-099;
Study Start Date:
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076713
Other Antiphospholipid Syndrome Studies:
1. Antiphospholipid Syndrome Collaborative Registry (APSCORE)
Related Studies:
Other Antiphospholipid Syndrome Clinical Trials
Other Indiana Clinical Trials
Other Muncie Clinical Trials
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
|
|
|
|
|
|
|
|
